Venture capital – Biotechnology and ICTInnova31, SCRRS, SA
Funding | Business angels & venture capital
Innova31 analyses investment proposals of newly-established business projects from all over Europe with consideration for the experience and capacity of the management team, the level of definition of the business concept or business plan (with a defined commercialisation strategy and a medium-term disinvestment strategy).
This venture capital company tries to provide the business project with the backing it requires to yield the maximum value. In addition to finding the company the required financial resources, it also therefore provides support in: the development of long-term strategy, professionalization of management and backing for the tasks of general management, the search for technological, commercial and strategic alliances, project consolidation, provision of permanent financial resources and consolidation of the business structure, access to technology, and business advice.
- Average investment size: €50,000 to €300,000
- Phase: start-up
- Sector: experience-based industries and health industries
- Geographical area: Catalonia, Spain and European Union
- Instrument: capital
- Companies financed: AIDA CENTRE, GENMEDICA THERAPEUTICS, COMERCIAL TV
Addressed to: Start-up or early stage companies based on the development of validated and patentable innovative technologies, with a development team clearly oriented to the generation of business that is motivated, professional and committed in the long-term, addressed to market segments with a high capacity for growth, and in business sectors with a clear technological profile.